Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates
Pearla Awad, Student Council, Cardiology Society Research Officer at RCSI Medical University of Bahrain, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Journal of Pediatrics, adding:
”Proud to share our latest publication in the European Journal of Pediatrics:
‘Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: a systematic review and meta-analysis of randomized controlled trials.’
In this study, we analyzed data from four randomized controlled trials involving 454 pediatric patients.
We found that liposomal iron is better tolerated, with fewer adverse effects and lower rates of constipation, while delivering comparable, and in some cases greater, hematologic outcomes compared to conventional oral iron.
Have a read.
This project was a great opportunity to explore an evolving therapeutic approach in pediatric hematology and contribute to the growing evidence supporting liposomal iron formulations. Grateful to all co-authors and collaborators for their contributions and teamwork throughout this project.”
Title: Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: A systematic review and meta-analysis of randomized controlled trials
Authors: Abdullah M. Alharran, Esraa Yousef Almutairi, Waleed Bader Alazemi, Fatemah Adel Alnejadah, Hasan S Hasan, Layal AlOufan, Asayel M Alsultan, Hala AlOmar, Maryam Alqayem, Joy Maasarani, Aljazi Alohaly, Pearla Awad, Abdullatif Alfehaid
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 6, 2026, 14:48Eliminating DOAC Interference in Routine Coagulation Assays – JTH
-
Jun 6, 2026, 14:35Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
-
Jun 6, 2026, 14:30Alan Nurden: Honoring the Legacy of Dr. Richard Aster
-
Jun 6, 2026, 14:17Danny Hsu: A Practice-Changing Milestone in Managing Post-Thrombotic Syndrome
-
Jun 6, 2026, 13:01Kathleen Freson: αIIbβ3’s Hidden Role in Platelet Production
-
Jun 6, 2026, 12:22Jonas Kingo: Factor XI at the Crossroads of Hormonal Regulation and Thrombosis at ISTH 2026
-
Jun 6, 2026, 12:06Reza Shojaei: Why Dried Plasma May Be the Most Important Plasma Innovation in Decades
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention